← SynDRA
dideoxyadenosine
SynDRA canonical compound SYN0078891 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | nucleoside reverse transcriptase inhibitor |
Mechanisms of action (all sources)
- nucleoside reverse transcriptase inhibitor
Drug classes
- Antimetabolites
- Antiviral Agents
Cross-references
Synonyms
- 2',3' Dideoxyadenosine
- ADENOSINE, 2',3'-DIDEOXY-
- ddAdo
- NSC 98700
- 4Q86AH641A
- 2'-3'-dideoxyadenosine
- DTXCID203771
- CHEBI:91207
- NSC98700
- ddA (Antiviral)
- RefChem:133288
- MFCD00010534
- dideoxy adenosine
- D2A
- [(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methanol
- NCGC00090791-03
- [(2S,5R)-5-(6-amino-9H-purin-9-yl)oxolan-2-yl]methanol
- [(2S,5R)-5-(6-aminopurin-9-yl)tetrahydrofuran-2-yl]methanol
- SMR000677932
- CCRIS 428
- CAS-4097-22-7
- EINECS 223-853-2
- BRN 0619924
- UNII-4Q86AH641A
- 2,3-deoxyladenosine
- [5-(6-aminopurin-9-yl)-2-oxolanyl]methanol
- ddA & GM-CSF
- Didanosine EP Impurity G
- Didanosine impurity G CRS
- 2', 3'-Dideoxyadenosine
- SCHEMBL3541
- DIDANOSINE IMPURITY G
- DIDEOXYADENOSINE [MI]
- 2',3'-Dideoxy-D-adenosine
- 5-26-16-00256 (Beilstein Handbook Reference)
- MLS001055366
- MLS006010855
- orb1745265
Look up dideoxyadenosine in the interactive SynDRA portal →